[Hyperfibrinogemia following activator therapy].
作者信息
Zawilska K, Jazienicki B
出版信息
Acta Haematol Pol. 1972 Jan-Mar;3(1):53-8.
PMID:4119480
Abstract
摘要
相似文献
1
[Hyperfibrinogemia following activator therapy].[激活剂治疗后高纤维蛋白原血症]
Acta Haematol Pol. 1972 Jan-Mar;3(1):53-8.
2
[Hypofibrinolysis in acute myocardial infarction (author's transl)].急性心肌梗死中的低纤维蛋白溶解（作者译）
Med Klin. 1974 Nov 22;69(47):1951-5.
3
Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.苯乙双胍加乙基雌烯醇用于心肌梗死幸存者：三年试点研究
Lancet. 1972 Sep 16;2(7777):556-9. doi: 10.1016/s0140-6736(72)91956-3.
4
Immunologic study of fibrinogen and its split products in venous thrombosis.
Acta Univ Carol Med Monogr. 1972;52:173-9.
5
Fibrinolytic activity and coronary-artery disease.
Lancet. 1968 May 11;1(7550):987-90. doi: 10.1016/s0140-6736(68)91104-5.
6
Thrombolytic therapy with streptokinase.
Med J Aust. 1970 Oct 31;2(18):839-46.
7
[Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
Voen Med Zh. 1993 Jun(6):45-7.
8
[Fibrinolytics. 46].[纤维蛋白溶解剂。46]。
Pharm Prax. 1970;6:141-2.
9
10
Streptokinase therapy in acute myocardial infarction.急性心肌梗死的链激酶治疗
Heart Lung. 1984 May;13(3):223-30.
Zotero 插件